© Francois Guenet / Inserm
Appointed by the French Council of Ministers on November 26, 2018, Gilles Bloch took up his post as Chairman and Chief Executive Officer of Inserm on January 2, 2019.
A graduate of the École Polytechnique, doctor, and researcher specializing in medical imaging, Gilles Bloch spent a large part of his career at the French Atomic Energy Commission before taking on major roles within research policy, including heading up the French National Research Agency upon its creation, and then being appointed Head of Research and Innovation at the Ministry of Higher Education and Research. Since 2015, he has chaired Université Paris-Saclay.
On the occasion of his new role, Gilles Bloch will present his New Year greetings to the press on Tuesday January 15, 2019 at 9 a.m., at Inserm headquarters.
Press contact and registration: firstname.lastname@example.org
Inserm and the Coalition for Epidemic Preparedness Innovations (CEPI) are holding a large conference entitled "Vaccines Against Emerging Infections – a Global Insurance" on 21 and 22 February 2017. It is especially aimed at emphasising the urgent need for action and the ...
L’Inserm se classe 9e dans le « Top 25 Global Innovators - Government » Reuters/Clarivate, qui évalue la capacité d’innovation des organisations publiques en fonction de l’impact de leur production scientifique et de leurs brevets. ...